Oxaliplatin combinating 5-fluorouracil and calcium folinic Acid Adjuvant chemotherapy after liver transplantation for hepatocellular carcinoma patients who do not meet Milan criteria

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-10000961

Enrollment

Unknown

Registered

2010-08-05

Start date

2005-02-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma (HCC)

Interventions

2:Adjuvant chemotherapy after liver transplantation

Eligibility

Sex/Gender

All

Age

34 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients who were excluded by Milan criteria, not with extrahepatic metastasis and the inferior vena cava tumor thrombus received liver transplantation; 2. The specimens of patients were pathologically diagnosed to be HCC; 3. Patients without tumor recurrence and metastasis after liver transplantation; 4. Patients volunteered to join, the patient or his legal representative sign a written on the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with abnorma liver function, leukopenia(400 ug/L); 4. Patients with poor compliance.

Design outcomes

Primary

Measure	Time frame
1. Survival duration; 2. Time to recurrence; 3. tumor free survival time; 4. Side- effects monitoring;	—

Countries

China

Contacts

Public ContactZhong-Yang Shen

zhongyangshen@gmail.com+86 010 88276839

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026